Chidamide Combined With Linperlisibon for the Treatment of Refractory/Relapsed Follicular Lymphoma
Clinical trial NCT06158386 · RECRUITING
Trial details
- NCT number
- NCT06158386
- Sponsor
- The First Affiliated Hospital of Xiamen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-22
- Primary completion
- 2027-12-31
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.